Cambridge, MA-based biotech firm Alkermes (NASDAQ:[[ticker:ALKS]]) said this morning that its chairman and former CEO Richard Pops is resuming the role of president and chief executive of the company. Pops, 47, was previously CEO of Alkermes between 1991 and April 2007. He replaces David Broeker, who has resigned from the CEO job and his seat on the company’s board of directors. Pops is remaining chairman of the board and taking over as CEO immediately, according to the company. Xconomy spoke to Pops in January 2009 about Alkermes’ future and business strategy. A spokeswoman for Alkermes was not immediately available to comment on the CEO change this morning.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
